803. PROHIBITED OFFICE LOCATIONS

803 PROHIBITED OFFICE LOCATIONS 803.1 An authorized practitioner recommending the use of medical cannabis to a qualifying patient shall not: Have a professional office located at or adjacent to an internet retailer or retailer, cultivation center, or testing laboratory; Have employees, agents, volunteers, or independent-contractors affiliated directly or indirectly with the authorized practitioner located at or adjacent to a medical cannabis business; or Receive financial compensation directly or indirectly from a medical cannabis business, or a director, officer, member, incorporator, agent, or employee of a medical cannabis business. 803.2 An authorized practitioner recommending the use of medical cannabis to a qualifying patient shall not have employees, agents, volunteers, or independent-contractors affiliated directly or indirectly with an internet retailer or retailer, cultivation center, or testing laboratory on the premises of the authorized practitioner’s professional office, clinic, or an institutional facility where the authorized practitioner sees patients or has privileges to see patients. 803.3 An authorized practitioner recommending the use of medical cannabis to a qualifying patient shall not have expediters or employees, agents, volunteers or independent-contractors affiliated directly or indirectly with an expediter on the premises of the authorized practitioner professional office, clinic, or an institutional facility where the authorized practitioner sees patients or has privileges to see patients. SOURCE: Emergency and Third Proposed Rulemaking published at 58 DCR 3299 (April 15, 2011)[EXPIRED]; as amended by Emergency and Fourth Proposed Rulemaking published at 58 DCR 7207 (August 12, 2011)[EXPIRED]; as amended by Final Rulemaking published at 58 DCR 10128, 10148 (December 2, 2011); as amended by Final Rulemaking published at 64 DCR 11922 (November 17, 2017); as amended by Final Rulemaking published at 65 DCR 3926 (April 13, 2018); as amended by Final Rulemaking published at 73 DCR 002136 (February 20, 2026). District of Columbia Municipal Regulations Medical Cannabis 22-C DCMR § 803